New Key Statistics Module, Z-Score and F-Score
NAS:ZBIO Key Ratios
Market Cap $ M | 877.33 |
Enterprise Value $ M | 690.57 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 7.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 50.00 |
EPS (TTM) $ | -1.02 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.24 |
EV-to-EBITDA | -12.26 |
PEG | -- |
Shares Outstanding M | 41.78 |
Net Margin (%) | -109.51 |
Operating Margin % | -112.87 |
Pre-tax Margin (%) | -108.91 |
Quick Ratio | 4.82 |
Current Ratio | 4.82 |
ROA % (ttm) | -54.62 |
ROE % (ttm) | -- |
ROIC % (ttm) | -405.46 |
Dividend Yield % | -- |
Altman Z-Score | -0.75 |
ZBIO Number of Guru Trades
ZBIO Volume of Guru Trades
Gurus Latest Trades with NAS:ZBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ZBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zenas BioPharma Inc Insider Transactions
No Available Data
News about NAS:ZBIO
Total 0- 1